Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score

Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study

Author:

Kang Matthew¹,Alahmadi Majed¹,Sawh Sonja²,Kovacs Michael J.¹,Lazo-Langner Alejandro¹³^ORCID

Affiliation:

1. Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada;

2. Pharmacy Services, London Health Sciences Centre, London, ON, Canada; and

3. Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada

Abstract

Key PointsFondaparinux seems to be an effective and safe alternative for the management of suspected HIT.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

Reference50 articles.

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Heparin-induced thrombocytopenia: An illustrated review;Research and Practice in Thrombosis and Haemostasis;2023-07